ZA201901942B - Nnif and nnif-related peptides and related methods - Google Patents

Nnif and nnif-related peptides and related methods

Info

Publication number
ZA201901942B
ZA201901942B ZA2019/01942A ZA201901942A ZA201901942B ZA 201901942 B ZA201901942 B ZA 201901942B ZA 2019/01942 A ZA2019/01942 A ZA 2019/01942A ZA 201901942 A ZA201901942 A ZA 201901942A ZA 201901942 B ZA201901942 B ZA 201901942B
Authority
ZA
South Africa
Prior art keywords
nnif
peptides
methods
related methods
related peptides
Prior art date
Application number
ZA2019/01942A
Other languages
English (en)
Inventor
Con Yost Christian
A Zimmerman Guy
S Weyrich Andrew
Schiffman Joshua
Original Assignee
The Univ Of Utah Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Univ Of Utah Research Foundation filed Critical The Univ Of Utah Research Foundation
Publication of ZA201901942B publication Critical patent/ZA201901942B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA2019/01942A 2016-09-02 2019-03-28 Nnif and nnif-related peptides and related methods ZA201901942B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662383243P 2016-09-02 2016-09-02
US201762492019P 2017-04-28 2017-04-28
PCT/US2017/050072 WO2018045371A2 (en) 2016-09-02 2017-09-05 nNIF AND nNIF-RELATED PEPTIDES AND RELATED METHODS

Publications (1)

Publication Number Publication Date
ZA201901942B true ZA201901942B (en) 2020-10-28

Family

ID=61309026

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/01942A ZA201901942B (en) 2016-09-02 2019-03-28 Nnif and nnif-related peptides and related methods

Country Status (13)

Country Link
US (1) US10857201B2 (enExample)
EP (1) EP3506924A4 (enExample)
JP (1) JP2019534247A (enExample)
KR (1) KR20190045271A (enExample)
CN (1) CN109937047A (enExample)
AU (1) AU2017321965A1 (enExample)
BR (1) BR112019004299A2 (enExample)
CA (1) CA3035770A1 (enExample)
MX (1) MX2019002479A (enExample)
RU (1) RU2019109049A (enExample)
SG (1) SG11201901830UA (enExample)
WO (1) WO2018045371A2 (enExample)
ZA (1) ZA201901942B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11324801B2 (en) 2016-09-02 2022-05-10 University Of Utah Research Foundation NNIF and nNIF-related peptides and related methods

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230158108A1 (en) * 2020-05-04 2023-05-25 University Of Utah Research Foundation Immunothrombosis in covid-19 acute respiratory distress syndrome
CN117004744B (zh) * 2022-04-27 2024-05-24 数字碱基(南京)科技有限公司 一种基于血浆微生物dna特征的肺癌预后评估方法及模型

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799766B2 (en) * 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
US9308235B2 (en) * 2012-05-09 2016-04-12 Spectrum Pharmaceuticals, Inc. Treatment of primary and metastatic carcinoma
EP4219534A3 (en) * 2013-07-08 2023-09-27 The University of Utah Research Foundation Methods for treatment of and prophylaxis against inflammatory disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11324801B2 (en) 2016-09-02 2022-05-10 University Of Utah Research Foundation NNIF and nNIF-related peptides and related methods

Also Published As

Publication number Publication date
BR112019004299A2 (pt) 2019-05-28
KR20190045271A (ko) 2019-05-02
AU2017321965A1 (en) 2019-04-04
CA3035770A1 (en) 2018-03-08
RU2019109049A (ru) 2020-10-05
EP3506924A4 (en) 2020-05-20
SG11201901830UA (en) 2019-03-28
US10857201B2 (en) 2020-12-08
WO2018045371A2 (en) 2018-03-08
US20190201487A1 (en) 2019-07-04
JP2019534247A (ja) 2019-11-28
MX2019002479A (es) 2019-09-19
WO2018045371A3 (en) 2018-04-12
CN109937047A (zh) 2019-06-25
RU2019109049A3 (enExample) 2020-12-24
EP3506924A2 (en) 2019-07-10

Similar Documents

Publication Publication Date Title
IL275307B (en) Syntac polypeptides and their uses
ZA201706420B (en) Transposase polypeptides and uses thereof
IL248175A0 (en) Psidine-deleting peptides and their uses
GB201603311D0 (en) New uses and methods
GB201400292D0 (en) Peptide dendrimers and agents
IL265834A (en) hla-restricted vgll1 peptides and their use
GB2563869B (en) Materials and methods
GB201416293D0 (en) Methods and preparations
GB201612858D0 (en) New uses and methods
SG11201705759SA (en) Cytotoxic hexim1 peptides and uses thereof
GB201607534D0 (en) Peptides
PL3565374T3 (pl) Sposoby i urządzenia do konfiguracji obszaru
GB201410031D0 (en) Polypeptides and uses thereof
IL287985A (en) A peptide derived from koc1 and a component containing it
GB201612150D0 (en) Modified peptide
GB2548839B (en) New uses and methods
GB201604468D0 (en) Peptides
GB201517786D0 (en) Methods and materials
PT3438118T (pt) Derivado de peptídeo e utilização deste
GB201607535D0 (en) Peptides
SG11201610918RA (en) Peptides and uses thereof
GB201401673D0 (en) Esculentin-2CHa peptide and analogues thereof
IL247448A0 (en) Peptides and methods of use
GB201617925D0 (en) Proteins and uses
GB201612665D0 (en) Peptides